Azashine 200mg Tablet

Introduction

Azashine is a medication that contains the active ingredient Azacitidine. It is available under the brand name Azashine. This medication is primarily used for the treatment of certain types of blood disorders and cancers, including myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).

Uses

Azashine is prescribed to patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). These conditions involve abnormal production of blood cells in the bone marrow, leading to a decrease in normal blood cell production and an increase in abnormal cells. Azashine helps in restoring normal blood cell production and slowing down the progression of these disorders.

Dosage and Administration

follow the dosage instructions provided by your healthcare professional. The dosage of Azashine may vary depending on your specific condition and medical history. The medication is typically administered as a tablet that is taken orally.

Mechanism of Action

Azashine contains Azacitidine, which is a type of medication known as a hypomethylating agent. It works by slowing down the growth of abnormal cells in the bone marrow and promoting the production of normal blood cells. This helps to restore a healthier balance of blood cells in the body.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, constipation, fatigue, and injection site reactions if administered as an injection. Serious side effects such as bone marrow suppression, liver problems, and allergic reactions are possible but rare.

If you experience any severe or persistent side effects, contact your healthcare provider immediately. They can provide guidance on how to manage these side effects or adjust your dosage if necessary.

Drug Interactions

Azashine may interact with other medications or substances. Inform your healthcare provider about all the medications you are taking, including prescription drugs, over-the-counter medications, and herbal supplements. Some medications, such as those that suppress the immune system, may interact with Azashine and affect its effectiveness or increase the risk of side effects. Your healthcare provider can provide more specific information about potential drug interactions.

Precautions

Before starting Azashine, let your healthcare provider know if you have any allergies, medical conditions, or if you are pregnant or breastfeeding. Certain medical conditions or medications may interact with Azashine and require special monitoring or adjustment of your treatment plan.

Follow all precautions advised by your healthcare provider. Azashine may not be suitable for everyone, and your healthcare provider will consider your individual circumstances when determining if this medication is appropriate for you.

Storage

Azashine should be stored at room temperature, away from moisture and heat. Keep the medication in its original container and make sure it is properly sealed. Do not store Azashine in the bathroom or any area with high humidity. Keep it out of reach of children and pets.

Patient Tips

• Take Azashine exactly as prescribed by your healthcare provider.
• If you miss a dose, contact your healthcare provider for further instructions. Do not take a double dose to make up for a missed one.
• attend all scheduled appointments with your healthcare provider for monitoring and evaluation.
• Stay hydrated and maintain a healthy diet while taking Azashine.
• If you have any questions or concerns about your medication, do not hesitate to contact your healthcare provider for clarification and guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Azacitidine 25 mg/ml powder for suspension for injection (Health Professionals SmPC) Available at:
• Azacitidine (Drugs.com) [Accessed 13 Jun. 2024] (online) Available at:
• azacitidine 300 mg tablet (RX) [Accessed 16 Jun. 2024] (online) Available at:
• Azacitidine (MedlinePlus) [Accessed 26 Jun. 2024] (online) Available at:
• [No authors listed] Azacitidine. IARC Monogr Eval Carcinog Risks Hum. 1990;50:47-63. [Accessed 16 Jun. 2024] Available at: